|
⚲
|
| Keyboard |
| Flagship Pioneering Fund VII LP
✚
|
|
|---|---|
| CIK # | 0001805916 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001805916] | |
| 4 | [0001805916] | |
| D | [0001805916] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
|
2026-03-02 | Conversion | 1,265,822 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series C Preferred Stock · derivative
|
2026-03-02 | Conversion | 2,531,644 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series C Preferred Stock · derivative
|
2026-03-02 | Conversion | 1,265,822 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series C Preferred Stock · derivative
|
2026-03-02 | Conversion | 2,109,704 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series A Preferred Stock · derivative
|
2026-03-02 | Conversion | 18,483,785 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series A Preferred Stock · derivative
|
2026-03-02 | Conversion | 17,016,215 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series A Preferred Stock · derivative
|
2026-03-02 | Conversion | 1,500,000 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
|
2026-03-02 | Conversion | 843,881 | $0.00 | |
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Conversion | 12,723,940 | ||
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Buy | 1,562,500 | $16.00 | 25,000,000 |
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Buy | 1,562,500 | $16.00 | 25,000,000 |
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Buy | 1,562,500 | $16.00 | 25,000,000 |
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Conversion | 2,777,752 | ||
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Conversion | 2,777,752 | ||
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Conversion | 987,491 | ||
|
Generate Biomedicines Inc GENB
Common Stock
|
2026-03-02 | Conversion | 13,702,224 | ||
|
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
|
2026-03-02 | Conversion | 2,953,586 | $0.00 | |
|
Generate Biomedicines Inc GENB
Series B Preferred Stock · derivative
|
2026-03-02 | Conversion | 2,109,704 | $0.00 | |
|
Generate Biomedicines Inc GENB
Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 29,561 | $0.00 | |
|
Foghorn Therapeutics Inc FHTX
Series 1 Warrants to purchase Common Stock · derivative
|
2026-01-13 | Grant | 1,117,734 | ||
| showing 20 of 25 most recent transactions | |||||